iBio announces private placement financing to raise ~$26M

iBio (IBIO) has announced a private placement financing to raise approximately $26 million through a securities purchase agreement with existing institutional investors. The company will sell 11.06 million shares at $2.35 each, with shares rising 16.17% pre-market to $2.73. The offering is expected to close around January 13, 2026, and aims to extend the company's cash runway into 2028, funding preclinical cardiometabolic programs and general corporate purposes.